Comment in response to “temozolomide in glioblastoma therapy: role of apoptosis, senescence and autophagy etc. by B. Kaina”
peer-reviewed
Erstveröffentlichung
2020-04-20Authors
Westhoff, Mike-Andrew
Baisch, Tim
Herbener, Verena J.
Karpel-Massler, Georg
Debatin, Klaus-Michael
Wissenschaftlicher Artikel
Published in
Biomedicines ; 8 (2020), 4. - Art.-Nr. 93. - eISSN 2227-9059
Link to original publication
https://dx.doi.org/10.3390/biomedicines8040093Institutions
UKU. Klinik für Kinder- und JugendmedizinUKU. Klinik für Neurochirurgie
Document version
published version (publisher's PDF)Subject headings
[GND]: Glioblastom | Strahlentherapie[MeSH]: Glioblastoma; Radiotherapy | Apoptosis | Temozolomide
[Free subject headings]: Temozolomide | Apoptosis Inducer | Fractionated radiation therapy
[DDC subject group]: DDC 610 / Medicine & health
Metadata
Show full item recordDOI & citation
Please use this identifier to cite or link to this item: http://dx.doi.org/10.18725/OPARU-42296
Westhoff, Mike-Andrew et al. (2022): Comment in response to “temozolomide in glioblastoma therapy: role of apoptosis, senescence and autophagy etc. by B. Kaina”. Open Access Repositorium der Universität Ulm und Technischen Hochschule Ulm. http://dx.doi.org/10.18725/OPARU-42296
Citation formatter >